pharmaphorum

FEBRUARY 29, 2024

It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.

Business Development 111

Business Development Development 111

Pharmaceutical Technology

MAY 26, 2023

Pharma company merger and acquisition (M&A) activity in the first half of 2023 has remained relatively low, consistent with the second half of last year, but investors predict deals will increase later in 2023. Experts at PWC, Goldman Sachs, and Morgan Stanley agree that pharma-related M&A is expected to pick up in 2023.

Life Science 130

Life Science Manufacturing Contract Manufacturing Gene Therapy 130

World of DTC Marketing

APRIL 19, 2022

I’m working with a top healthcare magazine on some research they conducted. You’re on top of trends that will affect your brand’s launch or growth in its life cycle. As times change, so do trends. Keeping up with the latest marketing trends can help your brand stick out to potential and current customers.

Marketing 192

Marketing Branding Production Development 192

Pharmaceutical Technology

DECEMBER 27, 2022

The Covid-19 pandemic pushed most markets into free fall, leading to increased wariness for completing large mergers and acquisitions (M&As) in the pharmaceutical sector. In December, fewer companies announced new deals, in line with trends seen in the past. However, the number of deals only tell one part of the story.

Life Science 130

Life Science Marketing Manufacturing Contract Manufacturing 130

World of DTC Marketing

DECEMBER 28, 2020

Another trend in the hype loop right now is digital health devices such as the Apple Watch. Sure more people might use these devices, but as a cardiologist told me, “I’m not going to trust any wearable to diagnose a patient.” Much has changed but a lot is also the same. Some are, but most aren’t.

Doctors 296

Doctors Doctor Production Marketing 296

Drug Channels

OCTOBER 17, 2023

Below, I review recent M&A trends and then examine the strategic objectives behind the acquisition of private-equity-backed OneOncology by AmerisourceBergen (Cencora) and another financial buyer. The Federal Trade Commission’s (FTC) has a newfound interest in the roll-up transactions that are creating practice management companies.

Drugs 74

Drugs 74

Pharmaceutical Technology

SEPTEMBER 5, 2022

In addition to this deal, and AstraZeneca’s previous collaborations with Accent Therapeutics and French biotechnology company Innate Pharma, the company has an extensive merger and acquisition (M&A) history within the oncology landscape. We want to be a sustainably growing company. In 2019, AstraZeneca entered a $6.9

FDA Approval 287

FDA Approval Clinical Trials Clinical Trials Development 287

World of DTC Marketing

AUGUST 19, 2020

Along with the M&A activity is another disturbing trend. I know, nothing in life is guaranteed but all this M&A activity means high drug prices as drug companies refill their bank accounts. Drug companies have slowed their stock buybacks after the Covid-19 crisis and spent their money instead on buying each other.

Drugs 217

Drugs Pharma Companies Marketing Development 217

FDA Law Blog

MARCH 4, 2024

HP&M), is pleased to announce that Director Anne Walsh will be speaking at the DIA Advertising and Promotion Regulatory Affairs Conference. Before joining HP&M, Ms. Hyman, Phelps & McNamara, P.C. (HP&M), FDA Law Blog readers can use the discount code 24SPKR150 for reduced registration fees.

Compliance 59

Compliance Regulation Production Development 59

Pharmaceutical Technology

DECEMBER 27, 2022

If recent mergers and acquisitions (M&A) are anything to go by, the interest in developing treatments for orphan disorders is only growing. Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced. Tracking the news.

Clinical Trials 306

Clinical Trials Clinical Trials Trials Vaccination 306

BioPharma Reporter

OCTOBER 1, 2020

The recent M&A trend in the cell and gene therapy space will be put under the spotlight at the CPhl Festival of Pharma.

Gene 59

Gene Gene Therapy Regulation Marketing 59

Scienmag

JANUARY 22, 2021

In a study published today in Science Advances, University of Hawai’i (UH) at M?noa noa oceanographers fully reconciled climate and carbon cycle trends of the past 50 million years–solving a controversy debated in the scientific […].

55

55

Drug Channels

DECEMBER 14, 2023

Below, I review recent M&A trends and then examine the strategic objectives behind the acquisition of private-equity-backed OneOncology by AmerisourceBergen (Cencora) and another financial buyer. The Federal Trade Commission’s (FTC) has a newfound interest in the roll-up transactions that are creating practice management companies.

Drugs 52

Drugs 52

FDA Law Blog

FEBRUARY 26, 2024

HP&M) proudly announces that Director Anne Walsh will be a featured panelist at the highly anticipated 2024 Women’s White Collar Defense Association (WWCDA®) Leadership Retreat and Annual Attorney Meeting. Hyman, Phelps & McNamara, P.C. (HP&M) The event is set to take place from March 4-6, 2024, in San Francisco, California.

Compliance 59

Compliance Regulation 59

World of DTC Marketing

JUNE 27, 2021

In researching research trends, Wegovy.com doesn’t have much traffic at all, but the DTC for the product has not started yet. I’m worried about the patients who will see this as a way to lose weight while eating cheeseburgers. The drug carries a potential risk for a type of thyroid tumor and has a boxed warning.

Drugs 194

Drugs Doctors Doctor Production 194

World of DTC Marketing

JANUARY 13, 2022

With the pandemic, that number has, I’m sure, become a lot less. 3hree: Online data indicates that people want more in fo rmation from advertised brands – Data for the top brands via Google trends shows that people want more information about drug side effects and prices in simple, easy-to-understand language. P L E A S E.

Branding 217

Branding Marketing Doctors Doctor 217

FDA Law Blog

JANUARY 8, 2024

If this all holds true, it will follow the upward trend of the 2023 year in deals. We’ve previously posted on the importance of regulatory diligence generally and DOJ’s recent Safe Harbor Policy for Voluntary Self-Disclosures of Criminal Conduct made in connection with M & A transactions. Not every diligence issue is a dealbreaker.

Regulation 69

Regulation Compliance Marketing 69

Rethinking Clinical Trials

OCTOBER 26, 2023

Fleurence, PhD, MSc Senior Advisor National Institutes of Health Joshua M.       Speakers Rachael L. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020. Rates are the highest among 20-39-year-olds.

Clinical Research 141

Clinical Research Clinical Trials Clinical Trials Research 141

World of DTC Marketing

NOVEMBER 23, 2020

We see a similar trend in the data from the Axios/Ipsos poll. Pfizer still has some logistics to work out but I’m confident that people will welcome this product and that it will partly restore trust in pharma. SUMMARY: Pfizer’s ad in newspapers around the U.S. Pfizer ran an ad today that is superb.

Vaccination 188

Vaccination Vaccine FDA Approval Clinical Trials 188

World of DTC Marketing

NOVEMBER 16, 2021

The pandemic led to more people going online for health information, and that trend will continue. But… Omnichannel has become a vast buzzword, but frankly, I’m seeing a lot of clients wasting vast amounts of money on omnichannel marketing. They want to be treated as individuals, not just as a number. Map it first.

Marketing 253

Marketing Doctors Doctor Sales 253

Drug Discovery World

DECEMBER 20, 2022

DDW’s Diana Spencer summarises the key trends likely to impact the market in 2023. . In its predictions for investment trends in the biotechnology sector, TechCrunch argues that AI will have a more expansive role. M&A activity will accelerate. There will be greater emphasis on diversity in clinical trials.

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

Intouch Solutions

FEBRUARY 8, 2022

Pharma reps also had to pivot, moving to more virtual engagements with physicians; this trend will likely stick. Marketing magazine MM+M recently reached out to several industry leaders, including Intouch B2D’s SVP, client services director, Shane Mayer, to get a sense of where things stand for healthcare marketers.

Sales 52

Sales Clinical Trials Clinical Trials Marketing 52

Intouch Solutions

APRIL 21, 2022

Ann Cave, SVP, Managing Director, Head of Intouch Seven, has been named one of the 25 Pinnacle Award recipients of 2022 by MM+M. As editor in chief Larry Dobrow said, “Medical marketing is an ever-changing business, which makes staying ahead of trends and new technologies almost a full-time job in itself.

Marketing 52

Marketing Branding 52

Intouch Solutions

APRIL 21, 2022

Ann Cave, SVP, Managing Director, Head of Intouch Seven, has been named one of the 25 Pinnacle Award recipients of 2022 by MM+M. As editor in chief Larry Dobrow said, “Medical marketing is an ever-changing business, which makes staying ahead of trends and new technologies almost a full-time job in itself.

Marketing 52

Marketing Branding 52

The Pharma Data

DECEMBER 23, 2020

23 2020 — From 2001 to 2016, out-of-pocket costs of evaluation and management (E/M) services and common diagnostic tests increased for neurology patients, according to a study published online Dec. percent of patients for E/M visits and by 23.1 WEDNESDAY, Dec. 23 in Neurology. percent, respectively). © 2020 HealthDay.

Research 52

Research 52

FDA Law Blog

MAY 31, 2022

The conference brings together leading regulators and a wide range of stakeholders to discuss current issues and trends of importance to FDA-regulated industries. s (HP&M) Ricardo Carvajal will be moderating a breakout session with Susan T. Hyman, Phelps & McNamara, P.C.’s

Regulation 52

Regulation Drugs Development 52

ACRP blog

NOVEMBER 13, 2023

These forces include: Mergers and Acquisitions (M&A) Exhaustion “Amir,” currently employed as Quality Assurance Director at a small, U.S.-based If true, this will be his third employment disruption due to M&A. He goes on to say, “It doesn’t seem to matter how good you are at your job. So he waited.

HR 52

HR Medicine Development Drugs 52

World of DTC Marketing

MARCH 3, 2022

I’m not even sure what the hell that means. INSIGHT: This trend has been going on for some time. Online health seekers will spend more time online, depending on the seriousness of the condition. INSIGHT: Yes, and no. It’s a huge mistake to think that Boomers aren’t using digital resources, including telehealth.

Research 143

Research Branding Doctors Doctor 143

pharmaphorum

JULY 12, 2022

billion in funding for digital health companies in 2020, ahead of the widespread adoption of technologies as an aid to delivering healthcare to people in lockdown, and according to Rock Health, ties in with an underlying trend of continued growth. All told, digital health companies raised $10.3 billion raised in 2021.

Marketing 83

Marketing 83

World of DTC Marketing

MARCH 29, 2022

The current role in healthcare has been in treatment with drugs that lower A1C, but most physicians don’t have “the talk” about weight with patients, and in fact, there is a trend to tell HCPs not to weigh patients when they come into the office. Men are also at a slightly higher risk of developing diabetes than women.

Development 231

Development Clinical Trials Clinical Trials Trials 231

Drug Discovery World

SEPTEMBER 6, 2023

1 Using data provided by DealForma for the period 1 January 2022 to 16 June 2023, Nature analysed the deal trends in the field. The second highest value deal was a partnership between Sanofi and IGM Biosciences for the discovery of immunoglobulin M (IgM) antibody agonists in March 2022. billion, up 40% from 2021.

Antibody 52

Antibody Development Sales Manufacturing 52

World of DTC Marketing

MARCH 29, 2021

I’m not saying that pharma should go on social media to answer all questions and claims, but ignoring these questions/comments is hiding under the table. Brands need to quantify the comments and decide which trends are worth addressing in the website’s content. So where is the disconnect? Nowhere to be found.

Branding 182

Branding Doctors Doctor Drugs 182

pharmaphorum

JANUARY 26, 2022

The data also confirm another big trend in digital health last year – consolidation in the sector – with 574 M&A deals, up 44% on the prior year. The data also confirm another big trend in digital health last year – consolidation in the sector – with 574 M&A deals, up 44% on the prior year. billion of the total.

Pharmacy 110

Pharmacy Clinical Trials Clinical Trials Trials 110

pharmaphorum

AUGUST 2, 2022

According to a trends report by MM+M , 29% of biopharma companies are cutting back on rep spending while almost 50% are increasing their spend on engaging HCPs. However, during the COVID-19 pandemic, this came to a grounding halt—all face-to-face visits were canceled, and reps had to find new ways to engage HCPs.

Sales 52

Sales Production Marketing 52

ACRP blog

NOVEMBER 13, 2023

These forces include: Mergers and Acquisitions (M&A) Exhaustion “Amir,” currently employed as Quality Assurance Director at a small, U.S.-based If true, this will be his third employment disruption due to M&A. He goes on to say, “It doesn’t seem to matter how good you are at your job. So he waited.

HR 59

HR Medicine Development Drugs 59

World of DTC Marketing

AUGUST 9, 2021

The annual MM&M/Deloitte Healthcare Marketers Trend Report showed that 86% of diagnostic device companies, 65% of pharma marketers, and over half of biotechs use social as a critical part of their marketing mix to reach HCPs. Doximity was flagged for having anti-vaccine information. Reaching 730,000 physicians and 1.9

Nurses 294

Nurses Marketing Pharma Companies Production 294

XTalks

DECEMBER 20, 2021

Xtalks spoke with experts from the food industry to discuss how their companies played a significant role in catering to these food trends. Xtalks spoke with experts from the food industry to discuss how their companies played a significant role in catering to these food trends. Plant-Based and Better-For-You.

Production 98

Production Branding Marketing Protein 98